EUVIMEDEUVIMED entdecken
Crossref

Molecular signatures of brain glycolysis dysfunction in Alzheimer's disease

Dongdong Jia, Mengzhu Li, Linhan Li, Qunsong Wang, Xi-Chen Zhu, Jiao Luo, Haitao Yu iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Dongdong Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Glycolysis, Brain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Wuxi Municipal Health Commission, Wuxi Science and Technology Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Impaired glucose metabolism, especially glycolytic arrest, is strongly associated with Alzheimer's disease (AD), but its systemic changes in the AD brain are not well defined. Materials and Methods Here, we performed an integrated analysis of AD brain transcriptomics, combined with cognitive scoring, tau pathology grading data, to reveal systemic alterations of 28 glycolysis‐related genes.

Results

Most genes, including glucose‐6‐phosphate isomerase ( GPI ), phosphofructokinase, muscle type ( PFKM ) and lactate dehydrogenase A ( LDHA ), were downregulated and correlated with cognitive decline (Mini‐Mental State Examination, Clinical Dementia Rating) and tau pathology severity (correlation analysis, p < 0.05). These genes exhibited robust diagnostic potential (receiver operating characteristic area under the curve = 0.679–0.803), highlighting their utility as early AD biomarkers. Notably, OVO‐like zinc finger 2 ( OVOL2 ), a transcriptional repressor of glycolysis, was upregulated in AD and positively associated with tau burden and the suppression of GPI , PFKM and LDHA . Functional studies demonstrated that OVOL2 knockdown restored glycolytic gene expression and attenuated tau pathology, suggesting that OVOL2 is a candidate upstream regulatory factor for AD metabolic disorders.

Conclusions

Taken together, glycolysis enzymes were systemically altered in AD progression, and OVOL2 may be a candidate upstream regulator, while GPI, PFKM and LDHA may be potential diagnostic and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGlycolysisBrainHumansMaleAgedFemaleAged, 80 and overTranscriptomeL-Lactate DehydrogenaseGlucose-6-Phosphate IsomeraseBiomarkerstau ProteinsPhosphofructokinasesGene Expression Profiling

Stichwörter der Autor:innen

Alzheimer's diseasecognitive impairmentglycolysistau pathologytranscriptomics

Substanzen

L-Lactate DehydrogenaseGlucose-6-Phosphate IsomeraseBiomarkerstau ProteinsPhosphofructokinases

Autor:innen und Institutionen

  • The Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China.
  • Department of Neurosurgery, Wuhan Central Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
  • Department of Neurology, Affiliated Wuxi Clinical College of Nantong University, Wuxi, Jiangsu, China.
  • Department of Rehabilitation Medicine, Dapeng New District Nan'ao People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, China.
  • Department of Fundamental Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, People's Republic of China.

ORCID-Profile: Haitao Yu

Förderung

  • National Natural Science Foundation of China
  • Wuxi Municipal Health Commission
  • Wuxi Science and Technology Development Foundation
  • Natural Science Foundation of Jiangsu Province
  • Youth Talent Support Project of Jiangsu Province for Science and Technology
  • Medical Development Foundation of Jiangnan University
  • Natural Science Foundation of Hubei Province
  • Wuhan Natural Science Foundation

Zitieren

APA

Jia, D., Li, M., Li, L., Wang, Q., Zhu, X. C., Luo, J., & Yu, H. (2025). Molecular signatures of brain glycolysis dysfunction in Alzheimer's disease. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16641

Vancouver

Jia D, Li M, Li L, Wang Q, Zhu XC, Luo J, et al. Molecular signatures of brain glycolysis dysfunction in Alzheimer's disease. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16641

BibTeX
@article{Jia2025,
  author = {Jia, Dongdong and Li, Mengzhu and Li, Linhan and Wang, Qunsong and Zhu, Xi-Chen and Luo, Jiao and Yu, Haitao},
  title = {Molecular signatures of brain glycolysis dysfunction in Alzheimer's disease},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16641}
}
Kostenlos starten →